Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 8-K, filed Sep 28, 2026
- Incorporated
- Delaware
- Filings on record
- 47 filings
- On EDGAR
- CIK 1802369
- Fiscal year ends
- December
- Filer status
- Emerging growth company
News 1
Prospectuses and Registrations 5
Ownership 8 of 28
- SCHEDULE 13G Large holder reported a passive stake Oct 16, 2026
- SCHEDULE 13D Large holder reported an active stake Oct 5, 2026
- SCHEDULE 13D Large holder reported an active stake Oct 2, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 1, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 29, 2026
Other 8 of 13
- EFFECT Notice that a registration became effective Sep 24, 2026
- S-1MEF Sep 24, 2026
- CERT Exchange certified a listing Sep 24, 2026
- 8-A12B Registration of a security for exchange listing Sep 22, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jul 31, 2026
- DRS Draft registration statement, submitted confidentially Jun 22, 2026
- D Aug 10, 2023
- D Jan 26, 2023
Everything here comes from ADARx Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.